GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India
· Delayed Price · Currency is INR 2,543.10
+33.80 (1.35%)
At close: Dec 5, 2025
BOM:500660 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 430,816 | 487,432 | 329,173 | 224,319 | 281,714 | 244,012 | Upgrade
|
| Market Cap Growth | 5.42% | 48.08% | 46.74% | -20.37% | 15.45% | 15.67% | Upgrade
|
| Enterprise Value | 410,564 | 466,472 | 313,334 | 211,499 | 270,099 | 237,483 | Upgrade
|
| Last Close Price | 2543.10 | 2840.33 | 1885.83 | 1256.53 | 1486.11 | 1262.72 | Upgrade
|
| PE Ratio | 45.10 | 52.55 | 55.80 | 36.73 | 16.62 | 68.13 | Upgrade
|
| Forward PE | 39.81 | 49.88 | 44.16 | 35.58 | 42.30 | 40.93 | Upgrade
|
| PS Ratio | 11.62 | 13.00 | 9.53 | 6.90 | 8.59 | 8.34 | Upgrade
|
| PB Ratio | 25.23 | 24.98 | 18.52 | 12.88 | 10.58 | 16.51 | Upgrade
|
| P/TBV Ratio | 25.35 | 25.15 | 18.77 | 13.14 | 10.72 | 17.01 | Upgrade
|
| P/FCF Ratio | 59.91 | 38.48 | 59.76 | 50.96 | 36.30 | 45.72 | Upgrade
|
| P/OCF Ratio | 57.96 | 37.79 | 56.56 | 46.33 | 34.75 | 42.22 | Upgrade
|
| PEG Ratio | 3.13 | 6.49 | 6.49 | 1.44 | 2.17 | 2.82 | Upgrade
|
| EV/Sales Ratio | 11.07 | 12.44 | 9.07 | 6.50 | 8.24 | 8.12 | Upgrade
|
| EV/EBITDA Ratio | 34.05 | 40.47 | 35.58 | 26.83 | 36.36 | 41.42 | Upgrade
|
| EV/EBIT Ratio | 35.72 | 41.86 | 37.35 | 28.26 | 38.65 | 45.71 | Upgrade
|
| EV/FCF Ratio | 57.10 | 36.82 | 56.89 | 48.05 | 34.80 | 44.50 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.01 | 0.02 | 0.02 | 0.03 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 0.05 | 0.01 | 0.03 | 0.04 | 0.03 | 0.07 | Upgrade
|
| Asset Turnover | 1.00 | 0.98 | 1.00 | 0.82 | 0.85 | 0.94 | Upgrade
|
| Inventory Turnover | 2.62 | 2.81 | 2.75 | 2.62 | 2.55 | 2.49 | Upgrade
|
| Quick Ratio | 1.43 | 1.50 | 1.45 | 1.50 | 1.83 | 1.02 | Upgrade
|
| Current Ratio | 1.78 | 1.79 | 1.84 | 1.88 | 2.18 | 1.63 | Upgrade
|
| Return on Equity (ROE) | 56.52% | 49.75% | 33.53% | 27.59% | 18.39% | 17.42% | Upgrade
|
| Return on Assets (ROA) | 19.39% | 18.17% | 15.24% | 11.75% | 11.28% | 10.39% | Upgrade
|
| Return on Capital (ROIC) | 41.88% | 37.07% | 29.52% | 21.07% | 20.82% | 19.24% | Upgrade
|
| Return on Capital Employed (ROCE) | 57.70% | 50.60% | 41.30% | 37.40% | 23.80% | 29.50% | Upgrade
|
| Earnings Yield | 2.22% | 1.90% | 1.79% | 2.72% | 6.02% | 1.47% | Upgrade
|
| FCF Yield | 1.67% | 2.60% | 1.67% | 1.96% | 2.76% | 2.19% | Upgrade
|
| Dividend Yield | 1.65% | 1.48% | 1.70% | 2.55% | 2.02% | 2.38% | Upgrade
|
| Payout Ratio | 96.18% | 80.79% | 91.80% | 249.80% | 29.89% | 189.04% | Upgrade
|
| Total Shareholder Return | 1.67% | 1.48% | 1.70% | 2.55% | 2.02% | 2.38% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.